Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03742024 · ClinicalTrials.gov registry record
Study of Pediatric Migraine: The Pediatric Migraine Registry
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 201
- Enrollment target
NCT03742024 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 201 participants.
The verdict
NCT03742024 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 201 participants
- Enrollment target
Study Summary
This is a multi-center registry that will prospectively collect regulatory compliant data from children and adolescents with migraine. This study will enroll approximately 200 participants from approximately 20 sites and will examine migraine symptoms, therapeutics used, and biomarkers associated with migraine.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 201 participants |
| Start Date | 2018-12-05 |
| Est. Completion | 2021-02-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03742024
The ClinicalTrials.gov registry entry for NCT03742024 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03742024 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03742024 about?
NCT03742024 is a clinical study titled "Study of Pediatric Migraine: The Pediatric Migraine Registry". This is a multi-center registry that will prospectively collect regulatory compliant data from children and adolescents with migraine. This study will enroll approximately 200 participants from approximately 20 sites and will examine migraine symptoms, therapeutics used, and biomarkers associated wi...
What is the current status of trial NCT03742024?
This trial is currently completed. The enrollment target is 201 participants. The study started on 2018-12-05. Estimated completion is 2021-02-08.
Who is sponsoring clinical trial NCT03742024?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.